BeOne Medicines (ONC) Current Taxes (2016 - 2026)
BeOne Medicines (ONC) posted quarterly Current Taxes of $63.5 million for Q1 2026, up 86.04% year-over-year from $34.1 million in Q1 2025, and up 52.61% quarter-over-quarter from $41.6 million in Q4 2025.
BeOne Medicines (ONC) Current Taxes (2016 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Current Taxes for 11 consecutive years, with $63.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Taxes rose 86.04% year-over-year to $63.5 million; the TTM figure through Mar 2026 stood at $63.5 million (up 86.04% YoY), while the FY2025 annual figure was $41.6 million, up 60.53% from the prior year.
- Current Taxes grew to $63.5 million in Q1 2026 per ONC's latest filing, from $41.6 million in the prior quarter.
- Across five years, Current Taxes topped out at $63.5 million in Q1 2026 and bottomed at $5.3 million in Q2 2024.
- Historically, Current Taxes has averaged $25.0 million across 5 years, with a median of $23.0 million in 2023.
- Annual changes were most pronounced in 2024 — Current Taxes sank 69.09% — and 2026, when it soared 86.04%.
- BeOne Medicines' Current Taxes stood at $25.2 million in 2022, then decreased by 8.88% to $23.0 million in 2023, then gained by 12.98% to $25.9 million in 2024, then soared by 60.53% to $41.6 million in 2025, then jumped by 52.61% to $63.5 million in 2026.
- Business Quant data shows ONC's Current Taxes at $63.5 million in Q1 2026, $41.6 million in Q4 2025, and $11.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 74.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.32 Mn |
| Mar 31, 2026 | 63.52 Mn |
| Dec 31, 2025 | 41.63 Mn |
| Sep 30, 2025 | 11.22 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Mar 31, 2025 | 34.14 Mn |
| Dec 31, 2024 | 25.93 Mn |
| Sep 30, 2024 | 14.88 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | 27.32 Mn |
| Dec 31, 2023 | 22.95 Mn |
| Sep 30, 2023 | 20.16 Mn |
| Jun 30, 2023 | 17.07 Mn |
| Mar 31, 2023 | 33.93 Mn |
| Dec 31, 2022 | 25.19 Mn |
| Sep 30, 2022 | 22.67 Mn |
| Jun 30, 2022 | 15.56 Mn |
| Mar 31, 2022 | 38.51 Mn |
| Dec 31, 2021 | 21.40 Mn |
| Sep 30, 2021 | 20.88 Mn |